137 related articles for article (PubMed ID: 26566973)
1. Association of various risk factors with chronic lymphocytic leukemia and its cytogenetic characteristics.
Karakosta M; Delicha EM; Kouraklis G; Manola KN
Arch Environ Occup Health; 2016 Nov; 71(6):317-329. PubMed ID: 26566973
[TBL] [Abstract][Full Text] [Related]
2. Population-based characterization of the genetic landscape of chronic lymphocytic leukemia patients referred for cytogenetic testing in British Columbia, Canada: the role of provincial laboratory standardization.
Gerrie AS; Huang SJ; Bruyere H; Dalal C; Hrynchak M; Karsan A; Ramadan KM; Smith AC; Tyson C; Toze CL; Gillan TL
Cancer Genet; 2014; 207(7-8):316-25. PubMed ID: 25441686
[TBL] [Abstract][Full Text] [Related]
3. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833
[TBL] [Abstract][Full Text] [Related]
5. Clinico-pathological impact of cytogenetic subgroups in B-cell chronic lymphocytic leukemia: experience from India.
Amare PS; Gadage V; Jain H; Nikalje S; Manju S; Mittal N; Gujral S; Nair R
Indian J Cancer; 2013; 50(3):261-7. PubMed ID: 24061469
[TBL] [Abstract][Full Text] [Related]
6. DNA repair polymorphisms associated with cytogenetic subgroups in B-cell chronic lymphocytic leukemia.
Ganster C; Neesen J; Zehetmayer S; Jäger U; Esterbauer H; Mannhalter C; Kluge B; Fonatsch C
Genes Chromosomes Cancer; 2009 Sep; 48(9):760-7. PubMed ID: 19484764
[TBL] [Abstract][Full Text] [Related]
7. Allelotyping in B-cell chronic lymphocytic leukemia (B-CLL).
Novak U; Tobler A; Fey MF
Leuk Lymphoma; 2004 May; 45(5):887-96. PubMed ID: 15291345
[TBL] [Abstract][Full Text] [Related]
8. Genomic aberrations and survival in chronic lymphocytic leukemia.
Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
[TBL] [Abstract][Full Text] [Related]
9. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
10. [Chromosomal aberrations in chronic lymphocytic leukemia by interphase fluorescence in situ hybridization and their association with clinical features].
Li WJ; Guo L; Hou M; Sun JZ; Shao LL; Wang SK; Ma DX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):494-8. PubMed ID: 20416197
[TBL] [Abstract][Full Text] [Related]
11. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.
Stilgenbauer S; Bullinger L; Lichter P; Döhner H;
Leukemia; 2002 Jun; 16(6):993-1007. PubMed ID: 12040431
[TBL] [Abstract][Full Text] [Related]
12. Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
Slager SL; Benavente Y; Blair A; Vermeulen R; Cerhan JR; Costantini AS; Monnereau A; Nieters A; Clavel J; Call TG; Maynadié M; Lan Q; Clarke CA; Lightfoot T; Norman AD; Sampson JN; Casabonne D; Cocco P; de Sanjosé S
J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):41-51. PubMed ID: 25174025
[TBL] [Abstract][Full Text] [Related]
13. Genomic characterization of chronic lymphocytic leukemia (CLL) in radiation-exposed Chornobyl cleanup workers.
Ojha J; Dyagil I; Finch SC; Reiss RF; de Smith AJ; Gonseth S; Zhou M; Hansen HM; Sherborne AL; Nakamura J; Bracci PM; Gudzenko N; Hatch M; Babkina N; Little MP; Chumak VV; Walsh KM; Bazyka D; Wiemels JL; Zablotska LB
Environ Health; 2018 May; 17(1):43. PubMed ID: 29720177
[TBL] [Abstract][Full Text] [Related]
14. Clinicobiologic importance of cytogenetic lesions in chronic lymphocytic leukemia.
Cavazzini F; Ciccone M; Negrini M; Rigolin GM; Cuneo A
Expert Rev Hematol; 2009 Jun; 2(3):305-14. PubMed ID: 21082972
[TBL] [Abstract][Full Text] [Related]
15. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
[TBL] [Abstract][Full Text] [Related]
16. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression.
Ottaggio L; Viaggi S; Zunino A; Zupo S; Rossi E; Spriano M; Abbondandolo A; Ferrarini M
Haematologica; 2003 Jul; 88(7):769-77. PubMed ID: 12857555
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J
Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397
[TBL] [Abstract][Full Text] [Related]
18. More extensive genetic alterations in unmutated than in hypermutated cases of chronic lymphocytic leukemia.
Karhu R; Tobin G; Thunberg U; Vilpo L; Sundström C; Knuutila S; Rosenquist R; Vilpo J
Genes Chromosomes Cancer; 2003 Aug; 37(4):417-20. PubMed ID: 12800154
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria.
Hernandez JM; Mecucci C; Criel A; Meeus P; Michaux I; Van Hoof A; Verhoef G; Louwagie A; Scheiff JM; Michaux JL
Leukemia; 1995 Dec; 9(12):2140-6. PubMed ID: 8609731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
